Point72 Asia (Singapore) Pte. Ltd. Erasca, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 9,565 shares of ERAS stock, worth $20,851. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,565Holding current value
$20,851% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ERAS
# of Institutions
117Shares Held
74.3MCall Options Held
7.1KPut Options Held
40.1K-
Arch Venture Management, LLC Chicago, IL11.1MShares$24.1 Million33.14% of portfolio
-
Black Rock Inc. New York, NY6.98MShares$15.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.17MShares$13.5 Million0.17% of portfolio
-
Artal Group S.A. Luxembourg, N44.72MShares$10.3 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.34MShares$9.46 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $266M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...